Abstract

PRO4 Uncertainty in Clinical Outcomes in the Treatment of Paediatric Orphan Indications with Licensed Therapies

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Weighing Clinical Evidence Using Patient Preferences: An Application of Probabilistic Multi-Criteria Decision Analysis.
Henk Broekhuizen ... Catharina G M Groothuis-Oudshoorn
PharmacoEconomics | VOL. 35
Henk Broekhuizen, et. al.Henk Broekhuizen ... Catharina G M Groothuis-Oudshoorn
10 Nov 2016
343 A benefit-risk assessment of daridorexant for the treatment of insomnia using patient preference data from two phase 3 trials
Sebastian Heidenreich ... Andrea Phillips-Beyer
Sleep | VOL. 44
Sebastian Heidenreich, et. al.Sebastian Heidenreich ... Andrea Phillips-Beyer
03 May 2021
Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma following autologous stem cell transplant: A cost-effectiveness analysis updated with 5-year follow-up data from the pivotal trial.
Christopher Parker ... Esprit Ma
Journal of Clinical Oncology | VOL. 34
Christopher Parker, et. al.Christopher Parker ... Esprit Ma
01 Mar 2016
PBI50 LEVERAGING OUTCOME BASED AND PORTFOLIO AGREEMENTS TO GUARANTEE CLINICAL OUTCOMES: INNOVATIVE PAYMENT MODELS FOR HIGH COST ONE-TIME TREATMENTS
P Madaan ... M Chalmers
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. 22
P Madaan, et. al.P Madaan ... M Chalmers
01 Nov 2019
View more papers

More From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Paper Title
Journal
Date
Author
How many Monte Carlo samples are needed for probabilistic cost-effectiveness analyses?
Reza Yaesoubi
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Reza YaesoubiReza Yaesoubi
06 Jul 2024
Three Pillars of Support for Orphan Drug Programs: Individual Valuations, Societal Valuations, and Anonymous Altruism
Darius N Lakdawalla ... Hong-Hanh Nguyen
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Darius N Lakdawalla, et. al.Darius N Lakdawalla ... Hong-Hanh Nguyen
06 Jul 2024
Generating utilities for the CS-Base: a novel, generic, and patient-centered health-outcome measure
Xin Zhang ... Paul Fm Krabbe
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Xin Zhang, et. al.Xin Zhang ... Paul Fm Krabbe
06 Jul 2024
Methods for measuring and valuing informal care: A systematic review and meta-analysis in stroke
Neha Das ... Lan Gao
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Neha Das, et. al.Neha Das ... Lan Gao
06 Jul 2024
View more papers